Competing interests
J.W., F.E., B.E., S.K., P.B. and A.B. report fees received for trial activities from Meridian Clinical Research that were funded by Moderna. X.S. and D.C.M. report funding from Moderna, Inc. for pseudovirus neutralization assays performed in the study. S.R.W. has conducted clinical trials funded by NIAID/NIH Moderna, Inc., Janssen Vaccines and Sanofi Pasteur. L.R.B. is a co-primary principal investigator of the COVE trial funded by NIAID and conducted in conjunction with Moderna, Inc. S.C., N.M., X.C., X.Z., A.S., B.G., D.K.E., J.F., H.Z., J.M.M. and R.D. are employees of Moderna, Inc. and may hold stock/stock options in the company. J.E.T. is a Moderna consultant.